Leonardus H.t. van der Ploeg, Chief Scientific Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 10,000 shares at $25.31 ($252K) on 2019-05-30, disclosed to the SEC on 2019-06-03.
Open-market sale of $252k RYTM by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.31 | 5,000 | $127K | 50.2% |
| 2 | $25.10 | 5,000 | $126K | 49.8% |
| Total | $25.20 avg | 10,000 | $252K | 100% |
| Filing → |
| RYTM | SELL | 2018-11-06 | $1.1M | — | Filing → |
| RYTM | SELL | 2018-09-27 | $1.9M | — | Filing → |